As a possible candidate for caspase-9 inhibition we tested the expression of the reported caspase-9 inhibitor of Apaf-1-mediated caspase-9 activation, TUCAN [11], in the panel of NSCLC and SCLC cells (Fig. 2). This evidence concerns the gene CASP9 and small cell lung carcinoma.